Hims & Hers CFO sells 29,277 shares, exercises options

The CFO’s exercise and sale were carried out under a Rule 10b5-1 trading plan adopted on May 20, 2026.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe exercised options for 14,000 Class A common shares at $5.01 per share and sold 29,277 shares at $29.95 per share on September 22, 2026. The option award was fully vested, and the exercise and sale were made under a Rule 10b5-1 trading plan adopted on May 20, 2026. After the exercise, he reported 66,872 options; 7,853 Class A common shares were held indirectly by the Oluyemi Okupe Separate Property Trust.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Okupe Oluyemi

Role Chief Financial Officer

Sold 29,277 shs ($877K)

Approx. gross sale proceeds $877K

Approx. exercise cost $70K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy) F1, F2	14,000	$0.00	$0.00
Exercise	Class A Common Stock F1	14,000	$5.01	$70K
Sale	Class A Common Stock F1	29,277	$29.95	$877K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 66,872 contracts (Direct); Class A Common Stock — 236,527 shares (Direct); Class A Common Stock — 7,853 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)

Footnotes (2)

1. F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.
2. F2. This stock option award is fully vested.

Key Figures

Shares sold: 29,277 Class A common shares Sale price: $29.95 per share Shares acquired through option exercise: 14,000 Class A common shares +3 more

6 metrics

Shares sold 29,277 Class A common shares Sold September 22, 2026

Sale price $29.95 per share Sale on September 22, 2026

Shares acquired through option exercise 14,000 Class A common shares Exercise on September 22, 2026

Exercise price $5.01 per share Option exercise on September 22, 2026

Options following exercise 66,872 options Direct position following the September 22, 2026 exercise

Trust-held shares 7,853 Class A common shares Held indirectly through the Oluyemi Okupe Separate Property Trust

Key Terms

Rule 10b5-1 trading plan, stock option award, fully vested

3 terms

Rule 10b5-1 trading plan regulatory

"effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

stock option award financial

"This stock option award is fully vested."

A stock option award is a grant that gives an employee the right to buy a company’s shares at a fixed price for a limited time, often becoming available gradually over a set schedule. Investors care because these awards align workers’ incentives with company performance, can increase employee loyalty, and may create future share dilution and compensation expense that affect earnings per share and shareholder value.

fully vested financial

"This stock option award is fully vested."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HIMS shares did the CFO sell, and at what price?

Chief Financial Officer Oluyemi Okupe sold 29,277 Class A common shares at $29.95 per share on September 22, 2026. The sale was made under a Rule 10b5-1 trading plan adopted on May 20, 2026.

How many HIMS stock options did the CFO exercise?

Oluyemi Okupe exercised options for 14,000 Class A common shares at $5.01 per share on September 22, 2026; the option award was fully vested. He reported 66,872 options following the exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 04:18 PM Accepted by SEC EDGAR 09/23/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/22/2026		M(1)		14,000	A	$5.01	265,804	D
Class A Common Stock	09/22/2026		S(1)		29,277	D	$29.95	236,527	D
Class A Common Stock								7,853	I	Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.01	09/22/2026		M(1)			14,000	(2)	02/23/2032	Class A Common Stock	14,000	$0	66,872	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

2. This stock option award is fully vested.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)